4.6 Review

Reappraising 21 years of the WHI study: Putting the findings in context for clinical practice

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Obstetrics & Gynecology

The impact of micronized progesterone on cardiovascular events - a systematic review

L. M. Kaemmle et al.

Summary: Research suggests that combining estrogen with MP does not significantly alter the risk of VTE/ATE or ischemic stroke, in contrast to norpregnane derivatives. However, studies on MI outcomes are lacking. More RCTs are needed to investigate the effects of MP alone or in combined MHT on vascular primary endpoints.

CLIMACTERIC (2022)

Article Obstetrics & Gynecology

Menopausal Hormone Therapy Formulation and Breast Cancer Risk

Haim A. Abenhaim et al.

Summary: The use of menopausal hormone therapy (HT) is associated with an increased risk of breast cancer, particularly with formulations containing synthetic progestins. However, the use of bioidentical estrogens or animal-derived estrogens is not associated with breast cancer. When prescribing HT, micronized progesterone may be the safer option.

OBSTETRICS AND GYNECOLOGY (2022)

Article Obstetrics & Gynecology

The 2022 hormone therapy position statement of The North American Menopause Society

Stephanie S. Faubion et al.

Summary: The 2022 Hormone Therapy Position Statement of NAMS updates the previous statement and provides recommendations for the use of hormone therapy in menopausal women. Hormone therapy is effective in treating vasomotor symptoms and preventing bone loss, but its risks vary depending on individual factors. It is important to assess the benefits and risks on an individual basis and regularly reevaluate the need for continued therapy.

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2022)

Review Endocrinology & Metabolism

Menopausal Hormone Therapy and Cardiovascular Disease: The Role of Formulation, Dose, and Route of Delivery

Chrisandra L. Shufelt et al.

Summary: Menopausal hormone therapy has varying effects on cardiometabolic markers and cardiovascular disease risk depending on formulation, dose, and route of delivery. Oral estrogens without progestogens have positive effects on lipoprotein levels, glycemia, insulin, and CVD risk, while adding progestogens blunts the lipid-related effects. Transdermal estrogens have less impact on coagulation, inflammation, and lipids compared to oral estrogens, potentially posing a lower risk of venous thromboembolism and stroke.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Public, Environmental & Occupational Health

Long term impact of the WHI studies on information-seeking and decision-making in menopause symptoms management: a longitudinal analysis of questions to a medicines call centre

Rifani B. Natari et al.

Summary: This study investigated the longitudinal impact of the WHI 2002 study on women's information-seeking and decision-making about managing menopausal symptoms. It found that women were influenced by negative media reports and safety concerns regarding hormone therapy still persisted over time. Information-seeking behaviors evolved over time as women sought reassurance and pursued alternative treatments.

BMC WOMENS HEALTH (2021)

Review Endocrinology & Metabolism

Impact of menopausal hormone therapy on colorectal cancer risk-A systematic review

Livia Nakhostin et al.

Summary: The effects of Menopausal Hormone Therapy (MHT) on the risk of colorectal cancer are heterogeneous, with a slight tendency towards neutral or protective effects. Although there are some positive effects on colorectal adenomas, MHT does not have significant impacts on tumor grade, subsite, and histologic types.

CLINICAL ENDOCRINOLOGY (2021)

Article Multidisciplinary Sciences

Conjugated equine estrogen used in postmenopausal women associated with a higher risk of stroke than estradiol

Wei-Chuan Chang et al.

Summary: This study found that in postmenopausal women in Taiwan, hormone therapy with oral conjugated equine estrogen (CEE) may be associated with a higher risk of ischemic stroke (IS) compared to estradiol (E2), especially when initiated within 5 years of menopause.

SCIENTIFIC REPORTS (2021)

Article Medicine, General & Internal

Menopausal hormone therapy and women's health: An umbrella review

Guo-Qiang Zhang et al.

Summary: The study comprehensively summarized 60 systematic reviews on the use of menopausal hormone therapy in women, revealing a complex balance of benefits and harms across multiple health outcomes. The findings suggest potential health risks associated with MHT, highlighting the importance of further research in this area.

PLOS MEDICINE (2021)

Article Peripheral Vascular Disease

Effects of menopausal hormone therapy on ambulatory blood pressure and arterial stiffness in postmenopausal Korean women with grade 1 hypertension: a randomized, placebo-controlled trial

Byung-Koo Yoon et al.

Summary: The study investigated the effects of combining micronized progesterone and percutaneous estradiol gel therapy on hemodynamics in postmenopausal Korean women with grade 1 hypertension. The results indicated that combined progesterone and estrogen therapy could reduce heart rate and arterial stiffness.

CLINICAL HYPERTENSION (2021)

Article Obstetrics & Gynecology

Effects of combined 17β-estradiol and progesterone on weight and blood pressure in postmenopausal women of the REPLENISH trial

Denise R. Black et al.

Summary: The study found that the impact of using E2/P4 on weight and blood pressure in postmenopausal women was modest and not clinically significant. There were no statistically meaningful differences compared to the placebo group.

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2021)

Article Obstetrics & Gynecology

The pharmacodynamics and safety of progesterone

Paul C. M. Piette

BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2020)

Article Obstetrics & Gynecology

Endometrial safety and bleeding profile of a 17β-estradiol/progesterone oral softgel capsule (TX-001HR)*

Sebastian Mirkin et al.

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2020)

Review Medicine, General & Internal

Osteoporosis

Juliet E. Compston et al.

LANCET (2019)

Review Obstetrics & Gynecology

The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?

Virginia M. Miller et al.

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2019)

Review Medicine, General & Internal

The Controversial History of Hormone Replacement Therapy

Angelo Cagnacci et al.

MEDICINA-LITHUANIA (2019)

Editorial Material Primary Health Care

The dangers of compounded bioidentical hormone replacement therapy

Louise Newson et al.

BRITISH JOURNAL OF GENERAL PRACTICE (2019)

Review Obstetrics & Gynecology

The evidence base for HRT: what can we believe?

R. D. Langer

CLIMACTERIC (2017)

Review Obstetrics & Gynecology

The impact of micronized progesterone on the endometrium: a systematic review

P. Stute et al.

CLIMACTERIC (2016)

Article Medicine, General & Internal

Menopause

Susan R. Davis et al.

NATURE REVIEWS DISEASE PRIMERS (2015)

Article Public, Environmental & Occupational Health

Risks of Endometrial Cancer Associated With Different Hormone Replacement Therapies in the E3N Cohort, 1992-2008

Agnes Fournier et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2014)

Review Biochemistry & Molecular Biology

Pharmacology of conjugated equine estrogens: Efficacy, safety and mechanism of action

Bhagu R. Bhavnani et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)

Review Biochemistry & Molecular Biology

Use of medroxyprogesterone acetate for hormone therapy in postmenopausal women: Is it safe?

Frank Z. Stanczyk et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)

Article Medicine, General & Internal

Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women's Health Initiative Randomized Trials

JoAnn E. Manson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

Article Endocrinology & Metabolism

Where Are We 10 Years After the Women's Health Initiative?

Roger A. Lobo

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)

Article Oncology

The effect of estrogen vs. combined estrogen-progestogen therapy on the risk of colorectal cancer

Kueiyu Joshua Lin et al.

INTERNATIONAL JOURNAL OF CANCER (2012)

Article Oncology

Estrogen Plus Progestin and Colorectal Cancer Incidence and Mortality

Michael S. Simon et al.

JOURNAL OF CLINICAL ONCOLOGY (2012)

Article Medicine, General & Internal

Health symptoms during midlife in relation to menopausal transition: British prospective cohort study

Gita D. Mishra et al.

BRITISH MEDICAL JOURNAL (2012)

Article Medicine, General & Internal

Estrogen therapy and coronary-artery calcification

JoAnn E. Manson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Obstetrics & Gynecology

Decline in use of hormone therapy among postmenopausal women in the United Kingdom

Usha Menon et al.

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2007)

Article Medicine, General & Internal

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause

Jacques E. Rossouw et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)

Article Health Care Sciences & Services

Brief report: Coronary heart disease events associated with hormone therapy in younger and older women

SR Salpeter et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2006)

Review Clinical Neurology

Perimenopausal mental disorders: Epidemiology and phenomenology

N Rasgon et al.

CNS SPECTRUMS (2005)

Letter Medicine, General & Internal

Breast cancer and hormone-replacement therapy: the Million Women Study - Reply

V Beral et al.

LANCET (2003)

Article Medicine, General & Internal

Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women

R Lindsay et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)